Featured Research Search Results

Using a Mobile Health App to Improve Quality of Life in Black Men with Prostate Cancer

Clinicaltrials.gov identifier:
NCT06651359

Quality of Life
Quality of life study for Black men with prostate cancer

Study of a New Oral Medication, Daraxonrasib After Surgery to Help Prevent Pancreatic Cancer from Returning

Clinicaltrials.gov identifier:
NCT07252232

Treatment
Phase 3 treatment trial for pancreatic cancer that was removed by surgery

Phase 3

ENGAGE: Surveys to Assess Decision-Making on Genetic Counseling and Testing for Lynch Syndrome

Clinicaltrials.gov identifier:
NCT07106359

Surveys, Registries, Interviews
Clinical trial for untested individuals at risk for Lynch syndrome

Share Your Child's Genetic Diagnostic Journey

Surveys, Registries, Interviews
Interview with Latino/a parents about their child's genetic care

Comparing Two Vaccine Treatments With Immunotherapy for Pancreatic Cancer Before and After Surgery

Clinicaltrials.gov identifier:
NCT06782932

Treatment
Treatment study for newly diagnosed pancreatic cancer that can be removed with surgery and who have not yet received treatment

Phase 1/2

Studying the Impact of Cancer-Related Financial Challenges on Couples’ Health

Surveys, Registries, Interviews
Survey for people who are receiving or have received cancer treatment and their partner

Comparing an Investigational Targeted Drug AZD5335 to Standard Treatments in People With Platinum‑Resistant Ovarian Cancer (TREVI‑OC‑01)

Clinicaltrials.gov identifier:
NCT07218809

Treatment
Treatment study for platinum-resistant ovarian cancer

Phase 3

Using a Blood Test to Detect Early Cancer Recurrence After Treatment (ORACLE)

Clinicaltrials.gov identifier:
NCT05059444

Treatment
Post-treatment study to monitor for recurrence

A Study for Women Having Revision Breast Implant Surgery

Clinicaltrials.gov identifier:
NCT05945329

Prevention
An interventional study for women undergoing revision breast implant surgery

SCREEN-CUP: Menstrual Cup Screening for Endometrial Cancer in Lynch Syndrome

Clinicaltrials.gov identifier:
NCT07220239

Prevention
Screening study for endometrial cancer

An Early Detection and Prevention Study for People with an Increased Risk of Cancer (InAdvance)

Clinicaltrials.gov identifier:
NCT05463796

Prevention
Study for people at risk of cancer, including previvors, survivors and family members

Genetic Testing for Cancer Risk for Black Families in Texas

Clinicaltrials.gov identifier:
NCT05694559

Prevention
Study to improve genetic counseling and testing to Black families in Texas

Comparing an Experimental Drug Puxi-Sam with Standard Chemotherapy for Metastatic Endometrial Cancer (Bluestar‑Endometrial01)

Clinicaltrials.gov identifier:
NCT07044336

Treatment
Phase 3 treatment study for metastatic endometrial cancer

Phase 3

Treating Advanced Solid Tumors with Targeted Therapies Called RAS(ON) Inhibitors Combined With the Targeted Immunotherapy Ivonescimab

Clinicaltrials.gov identifier:
NCT07397338

Treatment
Treatment study for solid tumors with a RAS mutation

Phase 1/2

Study of a New Targeted Therapy Given Alone or in Combination with an Immunotherapy for Metastatic, Triple-Negative Breast Cancer

Clinicaltrials.gov identifier:
NCT06841354

Treatment
Phase 3 treatment study for people with metastatic, triple-negative breast cancer

Phase 3

The EASE Study: Helping People with Advanced Cancer Cope with Fear of Cancer Progression

Clinicaltrials.gov identifier:
NCT07636200

Quality of Life
Quality of life study for people with advanced cancer experiencing anxiety

Perceptions of Gastric Cancer Risk and Attitudes Toward Endoscopic Surveillance in People with CDH1 or CTNNA1 Mutations

Surveys, Registries, Interviews
Online survey about gastric cancer risk and medical decision-making for people with an inherited CDH1 or CTNNA1 pathogenic variant

Treating Advanced Solid Tumors with a KRAS G12C Mutation Using Targeted Therapies Called RAS(ON) Inhibitors

Clinicaltrials.gov identifier:
NCT06128551

Treatment
Treatment study for advanced colorectal, pancreatic or lung cancer with a KRAS G12C mutation

Phase 1/2